CIK 0001437402 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 407.3 M | 52.2 M | ||
| Net income (USD) | -94.3 M | -94.9 M | ||
| Diluted EPS (USD/shares) | -0.26 | -0.42 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-08-25 | 4 | FORM 4 | 2026-08-21 |
| 2026-08-25 | 4 | FORM 4 | 2026-08-21 |
| 2026-08-25 | 4 | FORM 4 | 2026-08-21 |
| 2026-08-25 | 4 | FORM 4 | 2026-08-21 |
| 2026-08-25 | 4 | FORM 4 | 2026-08-21 |
| 2026-08-25 | 4 | FORM 4 | 2026-08-21 |
| 2026-08-25 | 4 | FORM 4 | 2026-08-21 |
| 2026-08-25 | 4 | FORM 4 | 2026-08-21 |
| 2026-08-21 | 144 | 144 | |
| 2026-08-21 | 144 | 144 | |
| 2026-08-21 | 144 | 144 | |
| 2026-08-21 | 144 | 144 | |
| 2026-08-21 | 144 | 144 | |
| 2026-08-21 | 144 | 144 | |
| 2026-08-21 | 144 | 144 | |
| 2026-08-21 | 144 | 144 | |
| 2026-08-17 | 8-K | 8-K items 8.01 | 2026-08-11 |
| 2026-08-14 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-11 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-10 | S-8 | S-8 | |
| 2026-08-06 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-06 | 8-K | 8-K items 2.02,7.01,9.01 | 2026-08-06 |
| 2026-07-17 | 4 | FORM 4 | 2026-07-15 |
| 2026-07-02 | 8-K | 8-K items 2.03,9.01 | 2026-06-29 |
| 2026-06-22 | 4 | FORM 4 | 2026-06-18 |
Forms on file (last 1,000): 4 558, 8-K 132, 144 86, SC 13G/A 39, 10-Q 32, 3 27, SC 13G 18, S-8 13. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ARDX (0.002 USD), /gw/filings/filings?ticker=ARDX&form=8-K, /gw/filings/facts?ticker=ARDX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange